Supplementary Methods

DMR profiling of HeLa cells using small molecules. To screen functional GPCRs in
HeLa cells, a library of GPCR agonists consisting of 113 known GPCR agonists and two control compounds (forskolin and IBMX) was assembled. These agonists include endogenous and synthetic agonists, covering > 150 known GPCRs. Forskolin is an activator for adenylyl cyclases, and IBMX is non-selective phosphodiesterase inhibitors. Each compound with the highest possible purity was purchased individually from commercial vendors (Supplementary Table 1 ).
All compounds were dissolved in DMSO, except for epinephrine, ATP, ADP, UTP and UDP which were dissolved in water. The compound storage plate was made by dispensing 2 µl of corresponding solution at a desired concentration into 96well deep volume compound source plates (Corning Inc.). The storage concentration was 10 mM for small organic molecules, and 1 mM for peptides and lipid molecules. All compound storage plates were stored at -80 o C. For screening, all compounds were directly diluted using 1x HBSS assay buffer, except for peptide and lipid molecules which were diluted using 1x HBSS containing 0.25% bovine serum albumin.
All compound solutions were then transferred into 384well compound source plates (Corning Inc). The screening dose was 10 µM for small organic molecules and 1 µM for both peptide and lipid agonists. At least two independent measurements were carried out. For each independent measurement, each compound was assayed in duplicate. The rest 154 wells were used as controls.
The real time DMR responses were obtained for each compound. Table 2 lists the information of all other compounds used in the present study.
Supplementary
RNA Interference. A small interfering RNA (siRNA) expression system was prepared using the psiRNAhH1GFPzeo vector (InvivoGen) according to the manufacturer' s protocol. To specifically knock down the human CK2 catalytic subunit in HeLa cells, a DNA sequence of 5 -GTACCAGACGTTAACAGACTA-3 (siCK2 -1) generating short hairpin RNAs were inserted into the siRNA expression vector using restriction enzymes Acc65I and HindIII. siRNA transfection was monitored by a GFP marker present in the plasmid under fluorescence microscopy. The mock transfection was used as the controls. The efficiency of the siRNA knockdown was examined using immunoblotting of HeLa lysates obtained after 24 hr transfection and lysed in mammalian protein extraction reagent solution (Pierce) containing both protease inhibitor cocktail (Roche) and phosphatase inhibitor cocktail (Roche). Cell lysates then were loaded on SDS-PAGE gels and enhanced chemiluminescence signals were captured with the Fluor-S imaging system (Bio-Rad). The Western blotting was probed with commercially available anti-hCK2 antibody (C-18; Santa Cruz Biotechnology). Figure S1 shows the DMR characteristics of distinct known CK2 inhibitors. Figure S2 shows the dose responses of both DMAT and TBB. Figure S3 shows the dose responses of adrenergic receptor agonists. Figure S4 and S5 show the impact of known adrenergic receptor antagonists on the epinephrine response as well as the epinephrine-induced potentiation of the TBB response. Figure S6 shows the impact of toxin treatment on both DMAT and TBB responses. Figure S7 shows the DMR characteristics of endogenous GPCRs, other than adrenergic receptors, and their impacts on the TBB and DMAT responses. The dose dependent DMR for epinephrine showed an EC 50 of 15.0 ± 3.7 nM to trigger its respective DMR (Fig. 3a , and Supplementary Fig. 3e ) and an EC 50 of 4.0 ± 0.4 nM (n =4) to potentiate the TBB-induced DMR (a-b). Various AR blockers, each at 10 µM, were included with the epinephrine to test for their ability to interfere with epinephrine enhancements of the TBB response. Neither the potent α 1 -AR blocker, prazosin, nor the β-blockers, betaxolol or propranolol, altered the potency of epinephrine to increase the TBB response (b). In contrast, the potent α 2 -blocker yohimbine suppressed and shifted the epinephrine DMR titration (c-d) as well as completely blocking the epinephrine increased TBB response (e-f). EC 50 values were calculated from the corresponding DMR traces. All error bars represent the standard deviations of at least 4 measurements. 
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